Le Lézard
Classified in: Health
Subjects: CCA, FVT

GNC Second Quarter 2018 Earnings Release, Webcast and Conference Call Scheduled for July 26, 2018


PITTSBURGH, July 9, 2018 /PRNewswire/ -- GNC (NYSE: GNC), a leading global specialty health, wellness and performance retailer, will release results for the second quarter of 2018 before the market opens on July 26, 2018.  A webcast and conference call to discuss the results will be held at 8:30 am Eastern Time that day.

To participate on the live call listeners in North America may dial 1-800-263-0877 and international listeners may dial 1-323-794-2094. It is encouraged that callers dial in 5-10 minutes prior to the start of the call.  In addition, a live webcast of the call will be available on www.gnc.com via the Investor Relations section under "About GNC." A replay of this webcast will be available through August 9, 2018.

About Us

GNC Holdings, Inc.  (NYSE: GNC), headquartered in Pittsburgh, PA, is a leading global specialty health, wellness and performance retailer.

GNC connects customers to their best selves by offering a premium assortment of heath, wellness and performance products, including protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. This assortment features proprietary GNC and nationally recognized third-party brands.

GNC's diversified, multi-channel business model generates revenue from product sales through company-owned retail stores, domestic and international franchise activities, third-party contract manufacturing, e-commerce and corporate partnerships. As of March 31, 2018, GNC had approximately 8,900 locations, of which approximately 6,700 retail locations are in the United States (including approximately 2,400 Rite Aid franchise store-within-a-store locations) and franchise operations in approximately 50 countries.

 

SOURCE GNC Holdings, Inc.


These press releases may also interest you

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...



News published on and distributed by: